Forecast: Import of Heparin for Therapeutic Use to the US

As of 2023, the US imported a significant volume of heparin, but expected imports from 2024 onward show a gradual decline. Forecast data suggests a year-on-year decrease in import volume, starting from 2.6849 million kilograms in 2024, dropping to 2.5732 million kilograms by 2028. This trend reflects an average annual decrease, or CAGR, highlighting a slow but steady reduction in imports.

Future trends to watch include:

• Changes in domestic heparin production or sourcing strategies that may impact import dependency.
• Policy and regulatory developments that could influence future import levels.
• Potential shifts in demand due to changes in therapeutic use patterns or emerging medical conditions influencing heparin consumption.